Finnish VC investor looks for Nordic investors in its new life science & health fund
Two Finnish foundations are among the seed investors of a new life science fund that aims to return at least 250 percent. ”We will now start negotiations with international investors,” says Pekka Simula, partner at Innovestor. The new fund’s management team hopes to replicate what other Nordic life science funds have achieved.
Finnish venture capital firm Innovestor has launched a new life science and health fund focusing on early stage opportunities in the Nordic and Baltic countries.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
